Skip to main content

Table 5 Demographic characteristic of 53 patients with CLLTs

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

Variables

Single segment (n = 38)

Multiple segments (n = 15)

P-value

Age (years)

49.6 ± 13.0

55.0 ± 14.2

0.155

Gender, M:F

37:1

15:0

0.526

Liver cirrhosis

  

0.362

 Present

31 (81.6%)

12 (80.0%)

 Absent

7 (18.4%)

3 (20.0%)

AFP (ng/ml)

209.2 ± 350.0

246.0 ± 409.3

0.591

Tumor size (cm)

  

0.560

 < 5

26 (68.4%)

9 (66.7%)

 ≥ 5

12 (31.6%)

6 (33.3%)

Tumor nodule number

  

0.986

 Single

33 (86.8%)

13 (86.7%)

 Multiple (≥ 2)

5 (13.2%)

2 (13.3%)

MVI

  

0.531

 Present

5 (13.2%)

3 (20.0%)

 Absent

33 (86.8%)

12 (80.0%)

Differentiation grade#

  

0.879

 I–II

35 (92.1%)

14 (93.3%)

 III–IV

3 (7.9%)

1 (6.7%)

Surgical methods

  

0.328

 Mesohepatectomy

10 (26.3%)

6 (100%)

 Extended left/right hepatectomy

28 (73.7%)

9 (0%)

 Duration operation (min)

197.1 ± 75.7

223.4 ± 49.6

0.291

 Blood loss (ml)

296.0 ± 220.9

403.6 ± 621.6

0.362

Surgical margin (cm)

  

0.713

 < 1.0

6 (15.8%)

3 (20.0%)

 ≥ 1.0

32 (84.2%)

12 (80.0%)

Overall complications

9 (23.7%)

4 (26.7%)

0.820

 Ascites (Grade I)

5 (13.2%)

3 (20.0%)

 Pulmonary inflammation (Grade II)

3 (7.9%)

1 (6.7%)

 Wound infection (Grade I)

1 (2.6%)

0 (0%)

 In-hospital mortality

0 (0%)

0 (0%)